haloperidol has been researched along with tert-butylhydroperoxide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Battaglia, A; Canonico, PL; Lombardi, G; Miglio, G; Papini, MG; Varsaldi, F | 1 |
1 other study(ies) available for haloperidol and tert-butylhydroperoxide
Article | Year |
---|---|
Cabergoline prevents necrotic neuronal death in an in vitro model of oxidative stress.
Topics: Cabergoline; Cell Death; Cell Survival; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Ergolines; Free Radicals; Haloperidol; Humans; Lipid Peroxidation; Models, Neurological; Necrosis; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Receptors, Dopamine D2; tert-Butylhydroperoxide; Tumor Cells, Cultured | 2002 |